The "Off-the-Shelf" Revolution: How Universal iPSC Lines...

added blog Health

2026-02-03 14:56:14 -

The "Off-the-Shelf" Revolution: How Universal iPSC Lines are Slashing Therapy Costs.

The biggest challenge for the global Induced Pluripotent Stem Cells Market has always been the high cost of custom, patient-by-patient production. In 2026, however, the industry is pivoting toward "Universal" or "Allogeneic" iPSC lines. These are cells that have been "stealthed" using CRISPR gene editing to remove the markers that trigger immune rejection. This allows a single master cell line...

0 Comments 0 Shares 6 Views 0 Reviews